Terms: = Colorectal cancer AND SRGAP3, MEGAP, 9901, ENSG00000196220, ARHGAP14, KIAA0411, WRP AND Treatment
2 results:
1. Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer.
Zhuang Z; Liu Z; Li J; Wang X; Xie P; Xiong F; Hu J; Meng X; Huang M; Deng Y; Lan P; Yu H; Luo Y
J Transl Med; 2021 Jun; 19(1):256. PubMed ID: 34112180
[TBL] [Abstract] [Full Text] [Related]
2. FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
Maiello E; Gebbia V; Giuliani F; Paoletti G; Gebbia N; Borsellino N; Cartenì G; Pezzella G; Manzione L; Romito S; Lopez M; Colucci G;
Ann Oncol; 2005 May; 16 Suppl 4():iv56-60. PubMed ID: 15923431
[TBL] [Abstract] [Full Text] [Related]
